Exact Sciences マネジメント
マネジメント 基準チェック /24
Exact Sciences' CEO is Kevin Conroy, appointed in Apr 2009, has a tenure of 15.5 years. total yearly compensation is $16.12M, comprised of 6.5% salary and 93.5% bonuses, including company stock and options. directly owns 0.39% of the company’s shares, worth MX$974.14M. The average tenure of the management team and the board of directors is 3.8 years and 5.6 years respectively.
主要情報
Kevin Conroy
最高経営責任者
US$16.1m
報酬総額
| CEO給与比率 | 6.5% |
| CEO在任期間 | 15.5yrs |
| CEOの所有権 | 0.4% |
| 経営陣の平均在職期間 | 3.8yrs |
| 取締役会の平均在任期間 | 5.6yrs |
経営陣の近況
Recent updates
CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$175m |
| Mar 31 2024 | n/a | n/a | -US$240m |
| Dec 31 2023 | US$16m | US$1m | -US$204m |
| Sep 30 2023 | n/a | n/a | -US$282m |
| Jun 30 2023 | n/a | n/a | -US$432m |
| Mar 31 2023 | n/a | n/a | -US$517m |
| Dec 31 2022 | US$14m | US$510k | -US$624m |
| Sep 30 2022 | n/a | n/a | -US$716m |
| Jun 30 2022 | n/a | n/a | -US$735m |
| Mar 31 2022 | n/a | n/a | -US$745m |
| Dec 31 2021 | US$15m | US$963k | -US$596m |
| Sep 30 2021 | n/a | n/a | -US$793m |
| Jun 30 2021 | n/a | n/a | -US$829m |
| Mar 31 2021 | n/a | n/a | -US$720m |
| Dec 31 2020 | US$20m | US$499k | -US$824m |
| Sep 30 2020 | n/a | n/a | -US$327m |
| Jun 30 2020 | n/a | n/a | -US$165m |
| Mar 31 2020 | n/a | n/a | -US$136m |
| Dec 31 2019 | US$19m | US$792k | -US$213m |
| Sep 30 2019 | n/a | n/a | -US$216m |
| Jun 30 2019 | n/a | n/a | -US$221m |
| Mar 31 2019 | n/a | n/a | -US$219m |
| Dec 31 2018 | US$7m | US$696k | -US$175m |
| Sep 30 2018 | n/a | n/a | -US$143m |
| Jun 30 2018 | n/a | n/a | -US$124m |
| Mar 31 2018 | n/a | n/a | -US$119m |
| Dec 31 2017 | US$13m | US$633k | -US$114m |
報酬と市場: Kevin's total compensation ($USD16.12M) is above average for companies of similar size in the MX market ($USD5.81M).
報酬と収益: Kevin's compensation has increased whilst the company is unprofitable.
CEO（最高経営責任者
Kevin Conroy (58 yo)
15.5yrs
在職期間
US$16,119,899
報酬
Mr. Kevin T. Conroy served as Independent Director of SomaLogic, Inc. since September 1, 2021, until January 2022. Mr. Conroy had served as an Independent Director of Adaptive Biotechnologies Corporation s...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman of The Board & CEO | 15.5yrs | US$16.12m | 0.39% MX$ 974.1m | |
| Executive VP & General Manager of Pipeline | no data | US$3.67m | 0.0084% MX$ 21.3m | |
| Executive VP & General Manager of Precision Oncology | no data | US$3.57m | 0.0072% MX$ 18.1m | |
| Chief Financial Officer | less than a year | データなし | データなし | |
| Chief Science Officer | 3.5yrs | データなし | データなし | |
| Chief Information Officer | 1.8yrs | データなし | データなし | |
| Associate Manager of Investor Relations | no data | データなし | データなし | |
| Chief Compliance Counsel & VP | 9.8yrs | データなし | データなし | |
| Senior VP | 2.8yrs | データなし | 0.0060% MX$ 15.1m | |
| Executive Vice President of Human Resources | 7.4yrs | US$2.71m | 0.042% MX$ 107.2m | |
| Emeritus Chief Science Officer | 3.8yrs | US$4.21m | データなし | |
| Chief Laboratory Officer | 9.3yrs | US$3.95m | データなし |
3.8yrs
平均在職期間
50yo
平均年齢
経験豊富な経営陣: EXAS *'s management team is considered experienced (3.8 years average tenure).
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman of The Board & CEO | 15.6yrs | US$16.12m | 0.39% MX$ 974.1m | |
| Independent Director | 14.3yrs | US$408.75k | 0.015% MX$ 38.9m | |
| Director | 1.8yrs | US$1.47m | 0.030% MX$ 75.0m | |
| Independent Director | 15.5yrs | US$406.25k | 0.038% MX$ 95.9m | |
| Independent Director | less than a year | データなし | 0.0029% MX$ 7.5m | |
| Independent Director | 3.6yrs | US$417.75k | 0.011% MX$ 27.6m | |
| Independent Director | 5.6yrs | US$411.75k | 0.017% MX$ 43.6m | |
| Independent Director | 4.3yrs | US$401.25k | 0.012% MX$ 31.5m | |
| Lead Independent Director | 10.3yrs | US$442.75k | 0.030% MX$ 76.0m |
5.6yrs
平均在職期間
63yo
平均年齢
経験豊富なボード: EXAS *'s board of directors are considered experienced (5.6 years average tenure).